AMG 102 and Avastin for Recurrent Malignant Glioma

Clinical trial NCT01113398 · COMPLETED

Trial details

NCT number: NCT01113398
Sponsor: Katy Peters
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme Gliosarcoma

Start date: 2010-08-01
Primary completion: 2014-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.